Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Thor Straten

Showing results (31-40 of 171) with videos related to

Pageof 18
Sort By:
Cancer Immunology, Immunotherapy : CII|February 8, 2012
Eleventh international conference on progress in vaccination against cancer (PIVAC-11), 10-13 October 2011, Copenhagen, DenmarkTania Køllgaard, Joost H van den Berg, Marco Donia, et al.
Cancer Biology & Therapy|October 18, 2008
A survivin specific T-cell clone from a breast cancer patient display universal tumor cell lysisRikke Baek Sørensen, Inge Marie Svane, Per Thor Straten, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
The universal character of the tumor-associated antigen survivinMads Hald Andersen, Inge Marie Svane, Jürgen C Becker, et al.
Journal of Translational Medicine|September 5, 2006
HLA-A24 and survivin: possibilities in therapeutic vaccination against cancerMads Hald Andersen, Rikke B Soerensen, Jürgen C Becker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Spontaneous immunity against Bcl-xL in cancer patientsMads Hald Andersen, Sine Reker, Pia Kvistborg, et al.
Oncoimmunology|December 18, 2012
Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytesMarco Donia, Eva Ellebaek, Mads Hald Andersen, et al.
Journal of Biomedicine & Biotechnology|July 10, 2010
Therapeutic cancer vaccines in combination with conventional therapyMads Hald Andersen, Niels Junker, Eva Ellebaek, et al.
Cancer Research|October 18, 2002
Identical T-cell receptor transcripts in multiple melanoma metastasesDavid Schrama, Eva Fuchs, Eva-Bettina Bröcker, et al.
Human Immunology|May 20, 2008
Characterization of a single peptide derived from cytochrome P450 1B1 that elicits spontaneous human leukocyte antigen (HLA)-A1 as well as HLA-B35 restricted CD8 T-cell responses in cancer patientsPia Kvistborg, Sine Reker Hadrup, Inge Marie Svane, et al.
Cancers|April 3, 2021
TAM Receptor Inhibition-Implications for Cancer and the Immune SystemPia Aehnlich, Richard Morgan Powell, Marlies J W Peeters, et al.
Pageof 18

Showing results (31-40 of 171) with videos related to

Sort By:
Pageof 18
Cancer Immunology, Immunotherapy : CII|February 8, 2012
Eleventh international conference on progress in vaccination against cancer (PIVAC-11), 10-13 October 2011, Copenhagen, DenmarkTania Køllgaard, Joost H van den Berg, Marco Donia, et al.
Cancer Biology & Therapy|October 18, 2008
A survivin specific T-cell clone from a breast cancer patient display universal tumor cell lysisRikke Baek Sørensen, Inge Marie Svane, Per Thor Straten, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
The universal character of the tumor-associated antigen survivinMads Hald Andersen, Inge Marie Svane, Jürgen C Becker, et al.
Journal of Translational Medicine|September 5, 2006
HLA-A24 and survivin: possibilities in therapeutic vaccination against cancerMads Hald Andersen, Rikke B Soerensen, Jürgen C Becker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2005
Spontaneous immunity against Bcl-xL in cancer patientsMads Hald Andersen, Sine Reker, Pia Kvistborg, et al.
Oncoimmunology|December 18, 2012
Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytesMarco Donia, Eva Ellebaek, Mads Hald Andersen, et al.
Journal of Biomedicine & Biotechnology|July 10, 2010
Therapeutic cancer vaccines in combination with conventional therapyMads Hald Andersen, Niels Junker, Eva Ellebaek, et al.
Cancer Research|October 18, 2002
Identical T-cell receptor transcripts in multiple melanoma metastasesDavid Schrama, Eva Fuchs, Eva-Bettina Bröcker, et al.
Human Immunology|May 20, 2008
Characterization of a single peptide derived from cytochrome P450 1B1 that elicits spontaneous human leukocyte antigen (HLA)-A1 as well as HLA-B35 restricted CD8 T-cell responses in cancer patientsPia Kvistborg, Sine Reker Hadrup, Inge Marie Svane, et al.
Cancers|April 3, 2021
TAM Receptor Inhibition-Implications for Cancer and the Immune SystemPia Aehnlich, Richard Morgan Powell, Marlies J W Peeters, et al.
Pageof 18